ReviewInternational journal of impotence research2026
Early penile prosthesis implantation in refractory ischaemic priapism: a narrative review.
Review in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischaemic priapism (IP) is a urological emergency that can lead to permanent erectile dysfunction (ED) and penile deformity if not promptly managed. Refractory ischaemic priapism (RIP), defined as IP persisting beyond 48 hours despite conventional interventions, necessitates a paradigm shift in treatment strategy. Early penile prosthesis (PP) implantation offers a proactive approach in surgical management to preserve penile function while minimising complications associated with delayed surgery. This review synthesises current evidence on early PP insertion for RIP, evaluating its advantages over delayed intervention. We examine the pathophysiological progression of IP, emphasising corporal smooth muscle necrosis and penile fibrosis, which render erectile function recovery unlikely even with successful detumescence. Limitations of shunting procedures are also discussed and emerging diagnostic tools highlighted, such as magnetic resonance imaging (MRI), for assessing irreversible corporal damage. Comparative analysis of early versus delayed PP insertion reveals superior patient satisfaction, lower revision rates, reduced penile shortening, and fewer perioperative complications with early implantation. Device selection, operative techniques, and risk mitigation strategies are also explored. Our findings support early PP implantation as the preferred management strategy for RIP, aligning with international guidelines. Further research is warranted to refine surgical protocols and optimise patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.